EMS 181184 (BMS), an analogue of pradimicin, was administered intraven
ously to neutropenic mice infected with either a fluconazole-susceptib
le or a fluconazole-resistant clinical isolate of Candida tropicalis.
EMS prolonged survival at doses >3 mg kg(-1) day(-1), and at higher do
ses reduced tissue counts in mice. EMS was less potent mg for mg than
amphotericin B. Combined EMS and amphotericin B were no more effective
than either of the individual drugs.